TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer.

James, ND, Liu, W, Pirrie, S et al. (19 more authors) (2023) TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer. BJU International, 131 (1). pp. 63-72. ISSN 1464-4096

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • James, ND
  • Liu, W
  • Pirrie, S
  • Kaur, B
  • Hendron, C
  • Ford, D
  • Zarkar, A
  • Viney, R
  • Southgate, E
  • Desai, A
  • Hussain, SA ORCID logo https://orcid.org/0000-0003-1552-511X
  • Barber, J
  • Syndikus, I
  • Malik, Z
  • Eswar, C
  • Mangar, S
  • Money‐Kyrle, J
  • Lydon, A
  • Van Der Voet, J
  • James, N
  • Zarkar, A
  • Ford, D
Copyright, Publisher and Additional Information:

© 2022 The Authors. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: #BladderCancer; #blcsm; #uroonc; cetuximab; chemoradiotherapy; clinical trial; feasibility; muscle-invasive bladder cancer
Dates:
  • Published: January 2023
  • Published (online): 16 August 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 12 Oct 2022 10:07
Last Modified: 12 Jul 2024 09:01
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1111/bju.15864
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics